ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
RSMDF is expected to report earnings to rise 4.64% to 24 cents per share on July 31
Q2'25
Est.
$0.25
Q1'25
Est.
$0.24
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.01
Q2'24
Est.
$0.21
The last earnings report on April 23 showed earnings per share of 23 cents, missing the estimate of 23 cents. With 363.00 shares outstanding, the current market capitalization sits at 32.67B.